Agenus Inc reports results for the quarter ended March 31 - Earnings Summary

• Agenus Inc AGEN.OQ reported a quarterly adjusted loss of $1.03​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-3.04. The mean expectation of four analysts for the quarter was for a loss of $1.65 per share. Wall Street expected results to range from $-1.85 to $-1.17 per share.

• Revenue fell 14.1% to $24.07 million from a year ago; analysts expected $26.38 million.

• Agenus Inc's reported EPS for the quarter was a loss of $1.03​.

• The company reported a quarterly loss of $25.32 million.

• Agenus Inc shares had risen by 132.6% this quarter and gained 27.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 13.4% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "hold"

• Wall Street's median 12-month price target for Agenus Inc is $7.00

This summary was machine generated from LSEG data May 13 at 05:50 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)